Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38α mitogen-activated protein kinase activity

Shuang Huang, Liguo New, Zhixing Pan, Jiahuai Han, Glen R. Nemerow

Research output: Contribution to journalArticle

120 Citations (Scopus)

Abstract

Overexpression of urokinase plasminogen activator (uPA) and its receptor (uPAR) has been well documented in a wide variety of tumor cells. In breast cancer, expression of uPA/uPAR is essential for tumor cell invasion and metastasis. However, the mechanism responsible for uPA/uPAR expression in cancer cells remains unclear. In the studies reported here, we show that endogenous p38 MAPK activity correlates well with breast carcinoma cell invasiveness. Treatment of highly invasive BT549 cells with a specific p38 MAPK inhibitor SB203580 diminished both uPA/uPAR mRNA and protein expression and abrogated the ability of these cells to invade matrigel, suggesting that p38 MAPK signaling pathway is involved in the regulation of uPA/uPAR expression and breast cancer cell invasion. We also demonstrated that SB203580-induced reduction in uPA/uPAR mRNA expression resulted from the destabilization of uPA and uPAR mRNA. Finally, by selectively inhibiting p38α or p38β MAPK isoforms, we demonstrate that p38α, rather than p38β, MAPK activity is essential for uPA/uPAR expression. These studies suggest that p38α MAPK signaling pathway is important for the maintenance of breast cancer invasive phenotype by promoting the stabilities of uPA and uPAR mRNA.

Original languageEnglish (US)
Pages (from-to)12266-12272
Number of pages7
JournalJournal of Biological Chemistry
Volume275
Issue number16
DOIs
StatePublished - Apr 21 2000

Fingerprint

Plasminogen Activators
Urokinase-Type Plasminogen Activator
p38 Mitogen-Activated Protein Kinases
Cells
Breast Neoplasms
Messenger RNA
Tumors
Urokinase Plasminogen Activator Receptors
Neoplasms
Protein Isoforms
Maintenance
Neoplasm Metastasis
Phenotype

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38α mitogen-activated protein kinase activity. / Huang, Shuang; New, Liguo; Pan, Zhixing; Han, Jiahuai; Nemerow, Glen R.

In: Journal of Biological Chemistry, Vol. 275, No. 16, 21.04.2000, p. 12266-12272.

Research output: Contribution to journalArticle

@article{5ae06f898602406e8707e48ae4489500,
title = "Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38α mitogen-activated protein kinase activity",
abstract = "Overexpression of urokinase plasminogen activator (uPA) and its receptor (uPAR) has been well documented in a wide variety of tumor cells. In breast cancer, expression of uPA/uPAR is essential for tumor cell invasion and metastasis. However, the mechanism responsible for uPA/uPAR expression in cancer cells remains unclear. In the studies reported here, we show that endogenous p38 MAPK activity correlates well with breast carcinoma cell invasiveness. Treatment of highly invasive BT549 cells with a specific p38 MAPK inhibitor SB203580 diminished both uPA/uPAR mRNA and protein expression and abrogated the ability of these cells to invade matrigel, suggesting that p38 MAPK signaling pathway is involved in the regulation of uPA/uPAR expression and breast cancer cell invasion. We also demonstrated that SB203580-induced reduction in uPA/uPAR mRNA expression resulted from the destabilization of uPA and uPAR mRNA. Finally, by selectively inhibiting p38α or p38β MAPK isoforms, we demonstrate that p38α, rather than p38β, MAPK activity is essential for uPA/uPAR expression. These studies suggest that p38α MAPK signaling pathway is important for the maintenance of breast cancer invasive phenotype by promoting the stabilities of uPA and uPAR mRNA.",
author = "Shuang Huang and Liguo New and Zhixing Pan and Jiahuai Han and Nemerow, {Glen R.}",
year = "2000",
month = "4",
day = "21",
doi = "10.1074/jbc.275.16.12266",
language = "English (US)",
volume = "275",
pages = "12266--12272",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "16",

}

TY - JOUR

T1 - Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38α mitogen-activated protein kinase activity

AU - Huang, Shuang

AU - New, Liguo

AU - Pan, Zhixing

AU - Han, Jiahuai

AU - Nemerow, Glen R.

PY - 2000/4/21

Y1 - 2000/4/21

N2 - Overexpression of urokinase plasminogen activator (uPA) and its receptor (uPAR) has been well documented in a wide variety of tumor cells. In breast cancer, expression of uPA/uPAR is essential for tumor cell invasion and metastasis. However, the mechanism responsible for uPA/uPAR expression in cancer cells remains unclear. In the studies reported here, we show that endogenous p38 MAPK activity correlates well with breast carcinoma cell invasiveness. Treatment of highly invasive BT549 cells with a specific p38 MAPK inhibitor SB203580 diminished both uPA/uPAR mRNA and protein expression and abrogated the ability of these cells to invade matrigel, suggesting that p38 MAPK signaling pathway is involved in the regulation of uPA/uPAR expression and breast cancer cell invasion. We also demonstrated that SB203580-induced reduction in uPA/uPAR mRNA expression resulted from the destabilization of uPA and uPAR mRNA. Finally, by selectively inhibiting p38α or p38β MAPK isoforms, we demonstrate that p38α, rather than p38β, MAPK activity is essential for uPA/uPAR expression. These studies suggest that p38α MAPK signaling pathway is important for the maintenance of breast cancer invasive phenotype by promoting the stabilities of uPA and uPAR mRNA.

AB - Overexpression of urokinase plasminogen activator (uPA) and its receptor (uPAR) has been well documented in a wide variety of tumor cells. In breast cancer, expression of uPA/uPAR is essential for tumor cell invasion and metastasis. However, the mechanism responsible for uPA/uPAR expression in cancer cells remains unclear. In the studies reported here, we show that endogenous p38 MAPK activity correlates well with breast carcinoma cell invasiveness. Treatment of highly invasive BT549 cells with a specific p38 MAPK inhibitor SB203580 diminished both uPA/uPAR mRNA and protein expression and abrogated the ability of these cells to invade matrigel, suggesting that p38 MAPK signaling pathway is involved in the regulation of uPA/uPAR expression and breast cancer cell invasion. We also demonstrated that SB203580-induced reduction in uPA/uPAR mRNA expression resulted from the destabilization of uPA and uPAR mRNA. Finally, by selectively inhibiting p38α or p38β MAPK isoforms, we demonstrate that p38α, rather than p38β, MAPK activity is essential for uPA/uPAR expression. These studies suggest that p38α MAPK signaling pathway is important for the maintenance of breast cancer invasive phenotype by promoting the stabilities of uPA and uPAR mRNA.

UR - http://www.scopus.com/inward/record.url?scp=0034697159&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034697159&partnerID=8YFLogxK

U2 - 10.1074/jbc.275.16.12266

DO - 10.1074/jbc.275.16.12266

M3 - Article

C2 - 10766865

AN - SCOPUS:0034697159

VL - 275

SP - 12266

EP - 12272

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 16

ER -